Presence of heparan sulfate proteoglycan in thyroid tissue.
Glycosaminoglycan (GAG) was extracted from the porcine thyroid gland with a buffer containing 5.3 M guanidine-HCl and proteolytic enzyme inhibitors and was fractionated by subsequent isodensity CsCl centrifugation. 60% of uronic acid positive materials was accumulated in the bottom one-fourth fraction with high buoyant density. More than 90% of this uronic acid positive material in the thyroid tissue was heparin or heparan sulfate (sensitive to nitrous acid treatment) and the rest was chondroitin sulfate or dermatan sulfate (sensitive to chondroitinase ABC treatment). When the accumulated high buoyant density GAG was analyzed on a Sepharose CL-6-B column, approximately 14% of the heparin sulfate were in the macromolecular portion as a form of proteoglycan because it was destroyed by the papain digestion or alkaline borohydride treatment which extensively digests protein or releases GAG from protein by the elimination reaction, respectively. This study demonstrates the existence of heparin sulfate proteoglycan in thyroid tissue for the first time.
D000818:Animals; D011508:Chondroitin Sulfate Proteoglycans / Q000032:analysis*; D002810:Chondroitinases and Chondroitin Lyases / Q000494:pharmacology; D006025:Glycosaminoglycans / Q000032:analysis*; D019812:Heparan Sulfate Proteoglycans; D006497:Heparan Sulfate / Q000032:analysis*; D010206:Papain / Q000494:pharmacology; D011509:Proteoglycans / Q000032:analysis*; D013552:Swine; D013961:Thyroid Gland / Q000032:analysis*
D011508:Chondroitin Sulfate Proteoglycans; D002810:Chondroitinases and Chondroitin Lyases; D006025:Glycosaminoglycans; D019812:Heparan Sulfate Proteoglycans; D006497:Heparan Sulfate; D010206:Papain; D011509:Proteoglycans